跳至主要内容
临床试验/NCT01184664
NCT01184664已完成3 期

Effects of a Combination of Varenicline and Transdermal Nicotine Patch on Post-quitting Urges to Smoke

Queen Mary University of London2 个研究点 分布在 1 个国家目标入组 117 人开始时间: 2011年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
117
试验地点
2
主要终点
Rating of urges to smoke one week after the target quit date assessed by Mood and Physical Symptoms Scale

研究概览

简要总结

Varenicline and nicotine replacement therapy (NRT) are both effective smoking cessation treatments. Anecdotally smokers who are finding their quit attempt difficult have reported benefiting from adding NRT to varenicline. This proof-of-principle placebo-controlled double-blind study will examine whether combining NRT and varenicline provides better withdrawal and craving relief than varenicline alone. A total of 120 smokers would be randomised to receive varenicline +15mg/16hr patch or varenicline + placebo patch. All participants will receive standard NHS Stop Smoking Service support. The primary outcome would be ratings of craving and withdrawal discomfort 24 hours and one week after the target quit date.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Smokers seeking treatment
  • Aged 18 and over
  • Consenting to take part in the trial

排除标准

  • Pregnant or breastfeeding
  • End-stage renal disease
  • Unable to fill in questionnaires in English
  • Previous allergy to Varenicline
  • Previous allergy to Nicotine Patches Previous allergy to varenicline

研究组 & 干预措施

Varenicline + Active Patch

Experimental

Participants will use varenicline (1mg BD) + an active, 15mg/16hr Nicotine Patch

干预措施: Nicotine Patch (Drug)

Varenicline + Active Patch

Experimental

Participants will use varenicline (1mg BD) + an active, 15mg/16hr Nicotine Patch

干预措施: Varenicline (Drug)

Varenicline + Placebo Patch

Placebo Comparator

Participants will use varenicline (1mg BD) + a Placebo Nicotine Patch

干预措施: Placebo (Drug)

Varenicline + Placebo Patch

Placebo Comparator

Participants will use varenicline (1mg BD) + a Placebo Nicotine Patch

干预措施: Varenicline (Drug)

结局指标

主要结局

Rating of urges to smoke one week after the target quit date assessed by Mood and Physical Symptoms Scale

时间窗: 1 week

Rating of urges to smoke will be assessed using the Mood and Physical Symptoms Scale

次要结局

  • Validated abstinence rates over weeks 1-12 post target quit date(12 weeks post target quit date)
  • Rating of withdrawal symptoms up to 4-weeks post quitting assessed by Mood and Physical Symptoms Scale(4-weeks post quitting)
  • Profile of all adverse effects reported up to 12-weeks post quitting(Up to 12-weeks post quitting)
  • Ratings of urges to smoke 24 hours after the target quit date(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Professor Peter Hajek

Professor of Clinical Psychology

Queen Mary University of London

研究点 (2)

Loading locations...

相似试验